Find, compare & contact
Pitavastatine (Pitavastatin) API Manufacturers & Suppliers

Looking for Pitavastatin API 147511-69-1?

Description:

Here you will find a list of producers, manufacturers and distributors of Pitavastatin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Pitavastatin 

Synonyms:

Pitavastatine , Pitavastatia , Pitavastatinum , Pitavastatin Calcium  

Cas Number:

147511-69-1 

DrugBank number:

DB08860 

Unique Ingredient Identifier:

M5681Q5F9P

Pitavastatin is a type of Statins

Statins are a widely prescribed class of pharmaceutical active ingredients (APIs) used for the treatment of high cholesterol and prevention of cardiovascular diseases. These medications work by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in the production of cholesterol in the liver.

Statins are categorized as lipid-lowering agents and are highly effective in reducing levels of low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol. By decreasing LDL cholesterol, statins help to prevent the formation of plaque in the arteries, reducing the risk of heart attacks and strokes.

There are several popular statins available on the market, including atorvastatin, simvastatin, rosuvastatin, and pravastatin. Each statin differs in terms of potency, dosing, and potential drug interactions, allowing healthcare professionals to select the most appropriate option for individual patients.

Statins are typically taken orally in the form of tablets or capsules and are available in different strengths. The dosage is determined by various factors such as the patient's cholesterol levels, cardiovascular risk, and response to treatment.

While statins are generally well-tolerated, they can have side effects such as muscle pain, liver dysfunction, and gastrointestinal disturbances. However, these side effects are relatively rare and are outweighed by the significant cardiovascular benefits of statin therapy.

In conclusion, statins are a vital subclass of pharmaceutical APIs used for managing high cholesterol and reducing the risk of cardiovascular diseases. They effectively lower LDL cholesterol levels and are an essential component of treatment plans for individuals with hyperlipidemia or a high risk of heart disease.

Pitavastatin (Statins), classified under Lipid-lowering agents

Lipid-lowering agents are a category of pharmaceutical active ingredients (APIs) that are widely used in the treatment of hyperlipidemia, a condition characterized by elevated levels of lipids (such as cholesterol and triglycerides) in the blood. These agents play a crucial role in managing lipid abnormalities and reducing the risk of cardiovascular diseases.

One of the most commonly prescribed lipid-lowering agents is statins. Statins work by inhibiting an enzyme called HMG-CoA reductase, which is responsible for the production of cholesterol in the liver. By blocking this enzyme, statins effectively lower cholesterol levels in the bloodstream.

Another class of lipid-lowering agents is fibric acid derivatives, which primarily target triglyceride levels. These agents activate a nuclear receptor known as PPAR-alpha, which regulates lipid metabolism. By activating PPAR-alpha, fibric acid derivatives enhance the breakdown of triglycerides and increase the elimination of fatty acids from the bloodstream.

Additionally, bile acid sequestrants are often used as lipid-lowering agents. These agents bind to bile acids in the intestine, preventing their reabsorption. As a result, the liver utilizes more cholesterol to produce new bile acids, leading to a decrease in circulating cholesterol levels.

Lipid-lowering agents are available in various formulations, including tablets, capsules, and suspensions, allowing for convenient administration. They are usually prescribed alongside lifestyle modifications, such as dietary changes and regular exercise, to optimize the management of hyperlipidemia.

It is important to note that the use of lipid-lowering agents should be under the supervision of a healthcare professional, as they may have potential side effects and interactions with other medications. Proper monitoring of lipid levels and regular follow-up visits are essential for ensuring the effectiveness and safety of these pharmaceutical agents.

• Shandong Octagon Chemicals Limited from China, product country of origin China
• SETV Global from India, product country of origin India
• Sinoway industrial Co.,Ltd from China, product country of origin China
• LGM Pharma from United States, product country of origin World
• Kolon Life Science from South Korea, product country of origin South Korea
• TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
• Strides Pharma Science from India, product country of origin Unknown
• Jiangxi Aifeimu Technology Co Ltd from China, product country of origin China
• API Corp. from Japan, product country of origin Japan
• WANBANG BIOPHARMA from China, product country of origin China
• DNP Fine Chemical Utsunomiya from Japan, product country of origin Japan
• MSN Labs. from India, product country of origin India
• Mylan from India, product country of origin India
• Hetero Drugs from India, product country of origin India
• Shaoxing Hantai Pharma from China, product country of origin China
• Lupin from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.